• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    6.33 Up 0.04(0.64%) Dec 19, 4:00PM EST
    |After Hours : 6.40 Up 0.07 (1.11%) Dec 19, 7:46PM EST
    Add to Portfolio
    Prev Close:6.29
    Open:6.60
    Bid:4.08 x 600
    Ask:N/A
    1y Target Est:11.33
    Beta:3.87
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:6.33 - 6.94
    52wk Range:3.11 - 7.82
    Volume:11,462,383
    Avg Vol (3m):3,823,450
    Market Cap:779.64M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 0.64%779.64M
    ABTUp 0.61%69.34B
    GSKUp 0.14%104.21B
    RHHBYDown 6.59%234.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.11
    Quarterly EPS Est (Dec-14) :0.23
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-4.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback